ClinConnect ClinConnect Logo
Search / Trial NCT01307475

Study of Quality of Life in Freeman-Sheldon Syndrome and Related Conditions

Launched by FREEMAN-SHELDON RESEARCH GROUP, INC. · Mar 1, 2011

Trial Information

Current as of June 02, 2025

Terminated

Keywords

Chronic Post Traumatic Stress Disorder Delayed Onset Post Traumatic Stress Disorder Post Traumatic Neuroses Posttraumatic Neuroses Post Traumatic Stress Disorders Posttraumatic Stress Disorders Ptsd Post Traumatic Stress Disorder Endogenous Depression Neurotic Depression Depressive Syndrome Melancholia Depressive Neurosis Unipolar Depression Depressive Symptoms Emotional Depression Quality Of Life

ClinConnect Summary

This study is a research project initiated by the graduate research student (Mikaela I. Poling) and assisted by the clinical genetics fellow and graduate student (Andrés Morales) in partial fulfilment the requirements for their Masters degrees in Clinical and Applied Physiology, under approval, direction, and supervision of the study PI (Rodger J. McCormick).

Mental Health and Congenital Deformities:

Apajasalo et al. (1998) found significantly decreased health-related quality of life versus controls among adults and youth ages with chondrodysplasias. Differences in adult scores were in th...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Freeman-Sheldon syndrome,
  • Sheldon-Hall syndrome,
  • Distal arthrogryposis type 1, or
  • distal arthrogryposis type 3
  • Deceased probands with enough clinical information available to satisfy study requirements
  • Probands who participated in a prior Freeman-Sheldon Research Group (FSRG)-study are automatically accepted, since their diagnoses have been confirmed by FSRG clinical faculty.
  • Probands with a reported qualifying diagnosis, who have not participated in a prior FSRG-study, will be required to complete the complete a survey from a prior study and provide photographs and any requested medical records to confirm their diagnoses.
  • Family members and other close contacts may enrol, so long as they have either resided with or had substantial and prolonged contact with a proband, who has an FSRG-verified qualifying diagnosis. Investigators will make the final decision on a case-by-case basis, based on information provided.
  • Exclusion Criteria:
  • Patients with other anomalies, not having one of the above syndromes, will not be accepted.
  • Deceased probands will not be accepted for analysis, without enough clinical data available to satisfy study data collection requirements.
  • Patients or parents of minor children not willing to give consent will not be included.
  • Family members or other contacts that neither resided with nor had substantial and prolonged contact with the proband.

About Freeman Sheldon Research Group, Inc.

Freeman-Sheldon Research Group, Inc. is a pioneering clinical research organization dedicated to advancing the understanding and treatment of rare genetic disorders, particularly Freeman-Sheldon syndrome. With a commitment to innovative research and patient-centric approaches, the organization collaborates with healthcare professionals, researchers, and patient communities to conduct rigorous clinical trials. By leveraging cutting-edge methodologies and a multidisciplinary team, Freeman-Sheldon Research Group aims to develop effective therapies and improve the quality of life for individuals affected by these conditions, fostering hope and progress in the field of genetic medicine.

Locations

Buckhannon, West Virginia, United States

Guatemala City, , Guatemala

Patients applied

0 patients applied

Trial Officials

Robert L Chamberlain, MD

Principal Investigator

Freeman-Sheldon Research Group, Inc.

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials